VERU INC.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation WI
Business Address 2916 N. MIAMI AVENUE, MIAMI, FL, 33127
Mailing Address 2916 N. MIAMI AVENUE, MIAMI, FL, 33127
Phone 3125959123
Fiscal Year End 0930
EIN 391144397
Financial Overview
FY2025
$60.42M
Total Assets
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 11, 2026 | View on SEC |
| 10-Q Quarterly financial report | February 11, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | January 28, 2026 | View on SEC |
| 8-K Current report of material events | December 17, 2025 | View on SEC |
| 10-K Annual financial report | December 17, 2025 | View on SEC |
| 4 Insider stock transaction report | December 9, 2025 | View on SEC |
| 4 Insider stock transaction report | December 9, 2025 | View on SEC |
| 4 Insider stock transaction report | December 9, 2025 | View on SEC |
| 4 Insider stock transaction report | December 9, 2025 | View on SEC |
| 4 Insider stock transaction report | December 9, 2025 | View on SEC |
Annual Reports
10-K December 17, 2025
- VERU INC. has a structured cybersecurity risk management program integrated into its broader risk framework.
- No major cybersecurity incidents or significant impacts on operations or financials have been reported.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.